Healthcare
Moderna, Inc.
MRNA$140.34+1.70%
Price is delayed.
Add to Watchlist
About Moderna, Inc.
Moderna is a biotechnology company that pioneered mRNA vaccine technology during COVID. Beyond COVID vaccines, they are developing mRNA-based treatments for cancer, respiratory viruses, and rare diseases. The mRNA platform allows them to develop new vaccines faster than traditional methods.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore